Title	Publication Date	Language	Citations
HIV-1 Vif, APOBEC, and Intrinsic Immunity	2008/01/01	English	255
The control of viral infection by tripartite motif proteins and cyclophilin A	2007/01/01		161
Integrase and integration: biochemical activities of HIV-1 integrase	2008/01/01	English	151
HIV-1 Nef: at the crossroads	2008/01/01	English	132
Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm	2008/01/01	English	116
Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line	2008/01/01	English	106
Host factors influencing susceptibility to HIV infection and AIDS progression	2007/01/01		88
MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes	2008/01/01	English	81
Compartmentalization of the gut viral reservoir in HIV-1 infected patients	2007/01/01	English	73
Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature	2008/01/01	English	66
Identifying HIV-1 dual infections	2007/01/01		64
Host proteins interacting with the Moloney murine leukemia virus integrase: Multiple transcriptional regulators and chromatin binding factors	2008/01/01	English	57
Turning up the volume on mutational pressure: Is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3)	2008/01/01	English	52
Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection	2008/01/01	English	51
Rapid spread of mouse mammary tumor virus in cultured human breast cells	2007/01/01	English	50
In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate	2007/01/01		49
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo	2007/01/01		47
APOBEC3G encapsidation into HIV-1 virions: which RNA is it?	2008/01/01	English	43
Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway	2008/01/01	English	41
Optimal design and validation of antiviral siRNA for targeting HIV-1	2007/01/01	English	41
Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection	2007/01/01		40
Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy	2008/01/01	English	38
Cofilin activation in peripheral CD4 T cells of HIV-1 infected patients: a pilot study	2008/01/01	English	35
The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion	2008/01/01	English	33
The HIV RNA setpoint theory revisited	2007/01/01	English	33
The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal	2008/01/01	English	31
H-index, mentoring-index, highly-cited and highly-accessed: how to evaluate scientists?	2008/01/01	English	28
A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus	2008/01/01	English	27
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS	2007/01/01	English	27
New and old complex recombinant HIV-1 strains among patients with primary infection in 1996–2006 in France: The French ANRS CO06 primo cohort study	2008/01/01	English	25